BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE was reported 10705 times

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 3 0.0375
1 ANION GAP 16 0.0252
2 OVARIAN ADHESION 2 0.0250
3 PYROGLUTAMATE INCREASED 3 0.0186
4 THYROID CANCER RECURRENT 2 0.0171
5 ANTI-THYROID ANTIBODY INCREASED 2 0.0159
6 SINUS RHYTHM 6 0.0138
7 DEAFNESS PERMANENT 2 0.0102
8 PELVIC ADHESIONS 2 0.0084
9 ULNAR NERVE INJURY 2 0.0083
10 VASCULAR ACCESS SITE COMPLICATION 2 0.0079
11 CHOLESTEROSIS 2 0.0078
12 DUCTUS ARTERIOSUS PREMATURE CLOSURE 3 0.0073
13 ACUTE TONSILLITIS 1 0.0063
14 SALPINGITIS 2 0.0063
15 PERIPHERAL NERVE LESION 2 0.0061
16 ACUTE LUNG INJURY 7 0.0059
17 ABNORMAL MENSTRUAL CLOTS 1 0.0057
18 INFUSION SITE DISCHARGE 10 0.0057
19 GLOBULINS INCREASED 2 0.0055
20 PERIODIC LIMB MOVEMENT DISORDER 2 0.0054
21 OVARIAN ENLARGEMENT 2 0.0052
22 ENDOCRINE OPHTHALMOPATHY 4 0.0046
23 CERVICAL RADICULOPATHY 3 0.0042
24 PIGMENTARY MACULOPATHY 2 0.0041
25 PRODUCT DOSAGE FORM ISSUE 2 0.0041
26 TYPE V HYPERLIPIDAEMIA 2 0.0041
27 INFUSION SITE VESICLES 2 0.0038
28 INFUSION SITE CELLULITIS 2 0.0038
29 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 2 0.0037
30 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 5 0.0037
31 COSTOCHONDRITIS 6 0.0037
32 OCCIPITAL NEURALGIA 2 0.0035
33 ROTAVIRUS INFECTION 2 0.0035
34 ADNEXA UTERI MASS 1 0.0035
35 DEVICE MAINTENANCE ISSUE 2 0.0034
36 INFUSION SITE INDURATION 5 0.0034
37 SCHIZOAFFECTIVE DISORDER 6 0.0034
38 SLEEP-RELATED EATING DISORDER 3 0.0032
39 BUNDLE BRANCH BLOCK 3 0.0032
40 HYPOPLASTIC LEFT HEART SYNDROME 2 0.0029
41 SUSPECTED SUICIDE 13 0.0028
42 ABSCESS BACTERIAL 1 0.0028
43 COMPLEX REGIONAL PAIN SYNDROME 4 0.0027
44 ORAL MUCOSAL EXFOLIATION 4 0.0026
45 ADHESIVE TAPE USE 1 0.0026
46 INFUSION SITE INFECTION 6 0.0026
47 DEVICE INFUSION ISSUE 6 0.0024
48 SCIATIC NERVE INJURY 2 0.0024
49 INFUSION SITE OEDEMA 2 0.0024
50 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 2 0.0024
51 INFUSION SITE IRRITATION 3 0.0023
52 PERIPHERAL NERVE INJURY 2 0.0023
53 CATHETER SITE PRURITUS 2 0.0023
54 INFUSION SITE DISCOLOURATION 2 0.0023
55 INFUSION SITE RASH 3 0.0022
56 CERUMEN IMPACTION 2 0.0022
57 ARNOLD-CHIARI MALFORMATION 2 0.0021
58 PRE-EXISTING CONDITION IMPROVED 13 0.0021
59 COARCTATION OF THE AORTA 2 0.0021
60 ANIMAL SCRATCH 2 0.0021
61 ADHESION 3 0.0020
62 CHOLECYSTITIS CHRONIC 13 0.0019
63 INFUSION SITE PAIN 25 0.0019
64 POLYCYSTIC OVARIES 3 0.0019
65 INFUSION SITE DISCOMFORT 2 0.0019
66 INFUSION SITE ERYTHEMA 16 0.0019
67 INFUSION SITE MASS 2 0.0018
68 COMPLETED SUICIDE 153 0.0018
69 COLONIC POLYP 3 0.0018
70 DRY AGE-RELATED MACULAR DEGENERATION 2 0.0018
71 CATHETER SITE DISCHARGE 2 0.0018
72 VASCULAR DEVICE INFECTION 8 0.0018
73 GASTROINTESTINAL BACTERIAL INFECTION 2 0.0017
74 INFUSION SITE SWELLING 11 0.0017
75 REACTION TO EXCIPIENT 4 0.0017
76 VERTIGO POSITIONAL 3 0.0017
77 FEBRILE INFECTION 2 0.0017
78 INFUSION SITE REACTION 5 0.0017
79 EMBOLISM ARTERIAL 2 0.0017
80 IATROGENIC INJURY 2 0.0016
81 CATHETER SITE PAIN 4 0.0015
82 INFUSION SITE HAEMORRHAGE 5 0.0015
83 EAR CONGESTION 4 0.0015
84 GASTRIC PERFORATION 4 0.0015
85 AGORAPHOBIA 2 0.0015
86 MENINGITIS VIRAL 2 0.0015
87 INFUSION SITE EXTRAVASATION 9 0.0014
88 CHRONIC FATIGUE SYNDROME 2 0.0014
89 ECHOCARDIOGRAM ABNORMAL 2 0.0014
90 HYPERVOLAEMIA 7 0.0014
91 CATAPLEXY 2 0.0014
92 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
93 SECONDARY ADRENOCORTICAL INSUFFICIENCY 2 0.0013
94 RUBBER SENSITIVITY 2 0.0013
95 PORTAL HYPERTENSION 4 0.0013
96 SINUS PAIN 3 0.0013
97 SUBSTANCE USE 2 0.0013
98 INFUSION SITE PRURITUS 4 0.0013
99 NASAL ULCER 2 0.0013
100 CYSTITIS INTERSTITIAL 2 0.0012
101 MITRAL VALVE PROLAPSE 2 0.0012
102 BILIARY DYSKINESIA 2 0.0012
103 GLIOBLASTOMA 2 0.0012
104 BLOOD PH DECREASED 2 0.0012
105 TENSION HEADACHE 5 0.0012
106 RECALLED PRODUCT 2 0.0012
107 HYPERREFLEXIA 4 0.0011
108 JUGULAR VEIN THROMBOSIS 2 0.0011
109 HEPATOTOXICITY 25 0.0011
110 ALCOHOL ABUSE 3 0.0011
111 FACIAL BONES FRACTURE 4 0.0011
112 NASAL OEDEMA 2 0.0011
113 METABOLIC ACIDOSIS 35 0.0011
114 VENTRICULAR ARRHYTHMIA 4 0.0011
115 OESOPHAGEAL SPASM 2 0.0011
116 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
117 INJECTION SITE CELLULITIS 2 0.0011
118 RESPIRATORY DEPRESSION 13 0.0011
119 MIGRAINE 101 0.0011
120 DERMATITIS CONTACT 12 0.0011
121 COMA SCALE ABNORMAL 3 0.0010
122 GALLBLADDER INJURY 2 0.0010
123 NASAL SEPTUM DEVIATION 2 0.0010
124 NECK INJURY 3 0.0010
125 COAGULOPATHY 17 0.0010
126 MIXED LIVER INJURY 3 0.0010
127 NIPPLE PAIN 2 0.0010
128 COMPULSIVE SHOPPING 2 0.0010
129 FAMILY STRESS 3 0.0010
130 INTERVERTEBRAL DISC DISORDER 4 0.0009
131 CATHETER SITE ERYTHEMA 2 0.0009
132 MULTIPLE DRUG OVERDOSE INTENTIONAL 3 0.0009
133 BLOOD TESTOSTERONE INCREASED 2 0.0009
134 INFUSION SITE BRUISING 2 0.0009
135 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
136 RHINITIS ALLERGIC 4 0.0009
137 MENINGITIS ASEPTIC 4 0.0009
138 IRON DEFICIENCY 4 0.0009
139 SUPRAVENTRICULAR EXTRASYSTOLES 3 0.0009
140 POISONING 11 0.0009
141 HEPATIC FIBROSIS 3 0.0009
142 METHAEMOGLOBINAEMIA 2 0.0009
143 NECK SURGERY 2 0.0009
144 MACULOPATHY 3 0.0008
145 POISONING DELIBERATE 8 0.0008
146 SINUS OPERATION 2 0.0008
147 WRONG DOSE 2 0.0008
148 VITAMIN D DEFICIENCY 8 0.0008
149 HAEMATOLOGICAL INFECTION 2 0.0008
150 TOXICITY TO VARIOUS AGENTS 137 0.0008
151 SCOLIOSIS 5 0.0008
152 MULTIPLE INJURIES 5 0.0008
153 HAEMOLYSIS 6 0.0008
154 CONCUSSION 6 0.0008
155 ORAL INFECTION 3 0.0008
156 MALABSORPTION 4 0.0008
157 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
158 SOMNAMBULISM 5 0.0008
159 POST-TRAUMATIC STRESS DISORDER 5 0.0007
160 ADRENAL INSUFFICIENCY 9 0.0007
161 BRADYPNOEA 2 0.0007
162 COLITIS ISCHAEMIC 5 0.0007
163 FIBROMYALGIA 18 0.0007
164 CLONUS 2 0.0007
165 ORAL FUNGAL INFECTION 2 0.0007
166 RED BLOOD CELL COUNT INCREASED 2 0.0007
167 HAND FRACTURE 5 0.0007
168 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
169 PANCREATIC CARCINOMA METASTATIC 2 0.0007
170 PRODUCT USE COMPLAINT 11 0.0007
171 FIBULA FRACTURE 2 0.0007
172 LUNG CANCER METASTATIC 2 0.0007
173 VOMITING PROJECTILE 2 0.0007
174 DRY THROAT 7 0.0007
175 DEVICE POWER SOURCE ISSUE 2 0.0007
176 SPINAL OSTEOARTHRITIS 6 0.0007
177 PHYSICAL DISABILITY 3 0.0007
178 SINUS HEADACHE 4 0.0007
179 FACIAL PAIN 6 0.0007
180 ATYPICAL PNEUMONIA 2 0.0007
181 BLOOD CULTURE POSITIVE 2 0.0007
182 CENTRAL VENOUS CATHETERISATION 2 0.0007
183 EMERGENCY CARE 2 0.0007
184 EXOSTOSIS 6 0.0007
185 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
186 PHARYNGITIS STREPTOCOCCAL 7 0.0006
187 RENAL FUNCTION TEST ABNORMAL 3 0.0006
188 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
189 ABDOMINAL ADHESIONS 2 0.0006
190 NON-CARDIAC CHEST PAIN 2 0.0006
191 POLYMYALGIA RHEUMATICA 2 0.0006
192 ORTHOPNOEA 2 0.0006
193 PNEUMONIA VIRAL 2 0.0006
194 VENTRICULAR HYPOKINESIA 2 0.0006
195 PHARYNGEAL SWELLING 6 0.0006
196 LYMPHOCYTE COUNT INCREASED 2 0.0006
197 CHOLECYSTECTOMY 7 0.0006
198 INJECTION SITE INFECTION 2 0.0006
199 DEAFNESS NEUROSENSORY 2 0.0006
200 DEPRESSED LEVEL OF CONSCIOUSNESS 24 0.0006
201 SKIN INJURY 2 0.0006
202 ANXIETY DISORDER 2 0.0006
203 PLANTAR FASCIITIS 2 0.0006
204 ECONOMIC PROBLEM 9 0.0006
205 VITAMIN D DECREASED 5 0.0006
206 DEPRESSION SUICIDAL 2 0.0006
207 TACHYPHRENIA 2 0.0006
208 CARDIO-RESPIRATORY ARREST 24 0.0006
209 WEIGHT FLUCTUATION 6 0.0006
210 HANGOVER 2 0.0006
211 HEART DISEASE CONGENITAL 2 0.0006
212 EAR INFECTION 15 0.0006
213 BRUXISM 3 0.0006
214 MAJOR DEPRESSION 4 0.0005
215 DEAFNESS UNILATERAL 3 0.0005
216 RESPIRATORY ARREST 15 0.0005
217 GASTRIC ULCER HAEMORRHAGE 3 0.0005
218 HYPOPHOSPHATAEMIA 4 0.0005
219 STREPTOCOCCAL INFECTION 3 0.0005
220 CHRONIC SINUSITIS 2 0.0005
221 TOOTH INFECTION 7 0.0005
222 PERONEAL NERVE PALSY 3 0.0005
223 SPINAL DISORDER 5 0.0005
224 ACIDOSIS 4 0.0005
225 INSURANCE ISSUE 8 0.0005
226 FOOD ALLERGY 4 0.0005
227 AFFECTIVE DISORDER 4 0.0005
228 RESPIRATORY ACIDOSIS 2 0.0005
229 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
230 PATENT DUCTUS ARTERIOSUS 2 0.0005
231 TRICUSPID VALVE INCOMPETENCE 4 0.0005
232 BRAIN INJURY 5 0.0005
233 UPPER RESPIRATORY TRACT INFECTION 23 0.0005
234 VITAMIN B12 DEFICIENCY 2 0.0005
235 POST PROCEDURAL INFECTION 4 0.0005
236 DEMYELINATION 2 0.0005
237 SELF-MEDICATION 2 0.0005
238 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
239 SPINAL STENOSIS 2 0.0005
240 POOR VENOUS ACCESS 5 0.0005
241 COMA 23 0.0005
242 INCONTINENCE 5 0.0005
243 MUSCLE FATIGUE 2 0.0005
244 AORTIC VALVE INCOMPETENCE 2 0.0005
245 FACIAL PARALYSIS 4 0.0005
246 MUSCULOSKELETAL DISCOMFORT 8 0.0005
247 HYSTERECTOMY 4 0.0005
248 SKIN LACERATION 5 0.0005
249 PULMONARY THROMBOSIS 5 0.0005
250 DYSPHEMIA 2 0.0005
251 TOOTH FRACTURE 5 0.0005
252 MENINGITIS 3 0.0004
253 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
254 GASTROINTESTINAL INFECTION 4 0.0004
255 FEEDING DISORDER 9 0.0004
256 RESTLESS LEGS SYNDROME 8 0.0004
257 HAEMOGLOBIN INCREASED 2 0.0004
258 DYSPAREUNIA 2 0.0004
259 NEPHROGENIC ANAEMIA 2 0.0004
260 ARTHRITIS INFECTIVE 2 0.0004
261 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
262 HEPATITIS 11 0.0004
263 ROSACEA 2 0.0004
264 GASTRITIS EROSIVE 2 0.0004
265 CARPAL TUNNEL SYNDROME 6 0.0004
266 SEASONAL ALLERGY 6 0.0004
267 SPINAL COLUMN STENOSIS 2 0.0004
268 SKIN ABRASION 2 0.0004
269 PRE-ECLAMPSIA 2 0.0004
270 ENDOMETRIOSIS 2 0.0004
271 MYOCLONUS 5 0.0004
272 SLEEP APNOEA SYNDROME 8 0.0004
273 HYPOVOLAEMIC SHOCK 2 0.0004
274 AFFECT LABILITY 4 0.0004
275 FAECES SOFT 3 0.0004
276 SINUSITIS 42 0.0004
277 INCORRECT DOSAGE ADMINISTERED 2 0.0004
278 COELIAC DISEASE 4 0.0004
279 SPINAL OPERATION 5 0.0004
280 CEREBRAL DISORDER 3 0.0004
281 LIMB INJURY 11 0.0004
282 SINUS DISORDER 8 0.0004
283 MUCOUS STOOLS 2 0.0004
284 FEELING DRUNK 3 0.0004
285 ABDOMINAL TENDERNESS 2 0.0004
286 ANEURYSM 2 0.0004
287 SNEEZING 9 0.0004
288 VEIN DISORDER 2 0.0004
289 TROPONIN INCREASED 3 0.0004
290 AMMONIA INCREASED 2 0.0004
291 BOWEL MOVEMENT IRREGULARITY 3 0.0004
292 ABDOMINAL INFECTION 1 0.0004
293 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
294 TRISMUS 2 0.0004
295 VARICOSE VEIN 2 0.0004
296 PELVIC PAIN 7 0.0004
297 FAILURE TO THRIVE 2 0.0004
298 TENDERNESS 4 0.0004
299 ANHEDONIA 10 0.0004
300 POLYARTHRITIS 2 0.0004
301 RESPIRATORY TRACT CONGESTION 6 0.0004
302 FOOD POISONING 2 0.0004
303 ABDOMINAL MASS 1 0.0004
304 PHOTOPHOBIA 7 0.0004
305 MYASTHENIA GRAVIS 3 0.0004
306 PRODUCT RESIDUE PRESENT 2 0.0004
307 GINGIVITIS 2 0.0004
308 SINUS CONGESTION 5 0.0004
309 BACK DISORDER 6 0.0004
310 SUBSTANCE ABUSE 3 0.0004
311 BACK INJURY 4 0.0004
312 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
313 ACUTE HEPATIC FAILURE 5 0.0004
314 ESCHERICHIA INFECTION 3 0.0004
315 DRUG LEVEL INCREASED 6 0.0004
316 DENTAL CARIES 4 0.0004
317 NERVE INJURY 4 0.0004
318 NECROSIS 2 0.0004
319 ATRIAL SEPTAL DEFECT 3 0.0004
320 NECK PAIN 20 0.0004
321 PRODUCT LEAKAGE 2 0.0004
322 CANDIDA INFECTION 6 0.0004
323 MITRAL VALVE INCOMPETENCE 4 0.0004
324 PAIN IN JAW 10 0.0004
325 HEPATOCELLULAR INJURY 5 0.0004
326 SINUS TACHYCARDIA 5 0.0004
327 SKIN ATROPHY 2 0.0003
328 HYPERVENTILATION 2 0.0003
329 ADENOVIRUS INFECTION 1 0.0003
330 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
331 SKIN WARM 2 0.0003
332 HYPERTRIGLYCERIDAEMIA 2 0.0003
333 RIB FRACTURE 7 0.0003
334 URINE ODOUR ABNORMAL 2 0.0003
335 CARDIOMYOPATHY 5 0.0003
336 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
337 CARDIAC PACEMAKER INSERTION 2 0.0003
338 ODYNOPHAGIA 2 0.0003
339 ROAD TRAFFIC ACCIDENT 14 0.0003
340 SYMPTOM RECURRENCE 2 0.0003
341 GASTROENTERITIS VIRAL 6 0.0003
342 HYPOAESTHESIA ORAL 5 0.0003
343 LEUKOCYTOSIS 6 0.0003
344 VIRAL INFECTION 11 0.0003
345 TENSION 2 0.0003
346 ENCEPHALOPATHY 8 0.0003
347 CARDIOMEGALY 4 0.0003
348 NERVE COMPRESSION 3 0.0003
349 BACTERIAL INFECTION 6 0.0003
350 TOOTH EXTRACTION 4 0.0003
351 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
352 POST PROCEDURAL COMPLICATION 6 0.0003
353 ROTATOR CUFF SYNDROME 4 0.0003
354 THERAPY NON-RESPONDER 14 0.0003
355 HAEMOGLOBIN ABNORMAL 2 0.0003
356 ERUCTATION 6 0.0003
357 HIATUS HERNIA 4 0.0003
358 EAR PAIN 6 0.0003
359 DEEP VEIN THROMBOSIS 20 0.0003
360 DISABILITY 6 0.0003
361 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
362 DEVICE DISLOCATION 13 0.0003
363 PRODUCT PHYSICAL ISSUE 6 0.0003
364 EMPHYSEMA 3 0.0003
365 BRONCHIECTASIS 2 0.0003
366 POSTOPERATIVE WOUND INFECTION 2 0.0003
367 PRODUCT TASTE ABNORMAL 4 0.0003
368 EYELID PTOSIS 3 0.0003
369 IMPAIRED GASTRIC EMPTYING 4 0.0003
370 BLOOD TESTOSTERONE DECREASED 2 0.0003
371 ARTHRITIS 23 0.0003
372 EAR DISCOMFORT 3 0.0003
373 EYE MOVEMENT DISORDER 2 0.0003
374 ECCHYMOSIS 2 0.0003
375 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
376 ONYCHOCLASIS 2 0.0003
377 ENCEPHALITIS 2 0.0003
378 MENTAL IMPAIRMENT 7 0.0003
379 HUNGER 4 0.0003
380 MASS 4 0.0003
381 INJECTION SITE URTICARIA 7 0.0003
382 DYSPEPSIA 28 0.0003
383 INJURY 20 0.0003
384 SCRATCH 3 0.0003
385 HEAD INJURY 9 0.0003
386 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
387 JOINT INJURY 6 0.0003
388 BODY HEIGHT DECREASED 3 0.0003
389 THIRST 5 0.0003
390 HEREDITARY ANGIOEDEMA 3 0.0003
391 IMPAIRED QUALITY OF LIFE 4 0.0003
392 DECREASED ACTIVITY 3 0.0003
393 TONGUE DISORDER 2 0.0003
394 HYPERTHYROIDISM 4 0.0003
395 TOOTHACHE 5 0.0003
396 FLUID RETENTION 14 0.0003
397 INTENTIONAL UNDERDOSE 2 0.0003
398 OVERDOSE 59 0.0003
399 HEADACHE 171 0.0003
400 ARTHROPOD BITE 2 0.0003
401 STEVENS-JOHNSON SYNDROME 6 0.0003
402 RESPIRATORY TRACT INFECTION 7 0.0003
403 MALNUTRITION 3 0.0003
404 THERAPEUTIC RESPONSE UNEXPECTED 12 0.0003
405 SKIN INFECTION 3 0.0003
406 HYDRONEPHROSIS 2 0.0003
407 BONE LOSS 4 0.0003
408 DYSARTHRIA 10 0.0003
409 BREAST TENDERNESS 2 0.0003
410 SUICIDE ATTEMPT 16 0.0003
411 MYOCARDIAL ISCHAEMIA 3 0.0003
412 OSTEOPENIA 4 0.0003
413 VERTIGO 16 0.0003
414 ILLNESS 27 0.0003
415 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
416 MATERNAL DRUGS AFFECTING FOETUS 2 0.0003
417 SEROTONIN SYNDROME 5 0.0003
418 PERICARDIAL EFFUSION 6 0.0003
419 UNINTENTIONAL MEDICAL DEVICE REMOVAL 3 0.0003
420 APHTHOUS ULCER 2 0.0003
421 LUNG INFECTION 4 0.0003
422 DEVICE INFORMATION OUTPUT ISSUE 2 0.0003
423 BRONCHITIS 19 0.0003
424 HAEMORRHOIDS 5 0.0003
425 CHOKING 5 0.0003
426 BONE DENSITY DECREASED 8 0.0003
427 NASAL CONGESTION 15 0.0003
428 MULTIPLE ALLERGIES 2 0.0003
429 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
430 KIDNEY INFECTION 5 0.0003
431 COVID-19 PNEUMONIA 3 0.0003
432 ATAXIA 3 0.0003
433 NASAL DISCOMFORT 2 0.0003
434 RENAL CYST 2 0.0003
435 BLOOD PRESSURE ABNORMAL 5 0.0003
436 GINGIVAL PAIN 2 0.0003
437 SEIZURE 29 0.0003
438 OBESITY 4 0.0003
439 ATRIAL FLUTTER 2 0.0003
440 WRIST FRACTURE 3 0.0003
441 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
442 HEPATITIS C 3 0.0002
443 SENSORY LOSS 2 0.0002
444 GASTROOESOPHAGEAL REFLUX DISEASE 20 0.0002
445 ACUTE KIDNEY INJURY 38 0.0002
446 SPEECH DISORDER 13 0.0002
447 FRUSTRATION TOLERANCE DECREASED 2 0.0002
448 NEURALGIA 6 0.0002
449 CHOLELITHIASIS 8 0.0002
450 HYPERAESTHESIA 2 0.0002
451 CHEST PAIN 45 0.0002
452 HAIR DISORDER 2 0.0002
453 PHARYNGITIS 3 0.0002
454 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
455 MENSTRUAL DISORDER 2 0.0002
456 HAIR COLOUR CHANGES 3 0.0002
457 AGEUSIA 6 0.0002
458 PNEUMONIA ASPIRATION 6 0.0002
459 TINNITUS 11 0.0002
460 INTENTIONAL DRUG MISUSE 5 0.0002
461 DYSPNOEA EXERTIONAL 9 0.0002
462 ASTHMA 27 0.0002
463 BRAIN OEDEMA 3 0.0002
464 ANXIETY 67 0.0002
465 ABSCESS LIMB 1 0.0002
466 RETCHING 5 0.0002
467 POOR QUALITY SLEEP 5 0.0002
468 BLOOD MAGNESIUM DECREASED 2 0.0002
469 BALANCE DISORDER 20 0.0002
470 MUSCLE STRAIN 2 0.0002
471 CORONARY ARTERY DISEASE 7 0.0002
472 CARDIAC MURMUR 2 0.0002
473 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
474 SEDATION 6 0.0002
475 URINARY TRACT INFECTION 39 0.0002
476 BEDRIDDEN 3 0.0002
477 BLOOD CALCIUM INCREASED 2 0.0002
478 GROIN PAIN 2 0.0002
479 PANCREATITIS 12 0.0002
480 BRADYCARDIA 12 0.0002
481 HEAD DISCOMFORT 4 0.0002
482 FALL 75 0.0002
483 CHEST DISCOMFORT 23 0.0002
484 THROMBOSIS 18 0.0002
485 MYOSITIS 2 0.0002
486 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
487 OROPHARYNGEAL DISCOMFORT 2 0.0002
488 NEUROPATHY PERIPHERAL 21 0.0002
489 TACHYPNOEA 3 0.0002
490 BACK PAIN 51 0.0002
491 CORONARY ARTERY OCCLUSION 3 0.0002
492 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
493 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
494 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
495 NIGHT SWEATS 7 0.0002
496 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
497 IRON DEFICIENCY ANAEMIA 2 0.0002
498 COVID-19 38 0.0002
499 DIVERTICULITIS 6 0.0002
500 HEPATIC ENCEPHALOPATHY 2 0.0002
501 APPENDICITIS 2 0.0002
502 SWELLING 20 0.0002
503 OSTEOARTHRITIS 9 0.0002
504 STAPHYLOCOCCAL INFECTION 7 0.0002
505 GASTROINTESTINAL DISORDER 19 0.0002
506 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
507 UNEVALUABLE EVENT 16 0.0002
508 FOOT FRACTURE 4 0.0002
509 SPUTUM DISCOLOURED 2 0.0002
510 CHRONIC KIDNEY DISEASE 16 0.0002
511 NERVOUSNESS 11 0.0002
512 PRODUCT PACKAGING ISSUE 2 0.0002
513 INSOMNIA 56 0.0002
514 FUNGAL INFECTION 7 0.0002
515 RED BLOOD CELL COUNT DECREASED 6 0.0002
516 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
517 DRY MOUTH 17 0.0002
518 GAIT INABILITY 7 0.0002
519 ABDOMINAL PAIN UPPER 43 0.0002
520 PARAESTHESIA ORAL 3 0.0002
521 CONTUSION 20 0.0002
522 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
523 EMOTIONAL DISTRESS 25 0.0002
524 DYSTONIA 4 0.0002
525 CARDIAC ARREST 17 0.0002
526 GASTROENTERITIS 3 0.0002
527 SURGERY 12 0.0002
528 MEMORY IMPAIRMENT 28 0.0002
529 PARAESTHESIA 32 0.0002
530 TACHYCARDIA 18 0.0002
531 URINARY INCONTINENCE 6 0.0002
532 SKIN HAEMORRHAGE 3 0.0002
533 HEART RATE INCREASED 20 0.0002
534 HYPERHIDROSIS 26 0.0002
535 PULMONARY MASS 3 0.0002
536 HYPOTONIA 2 0.0002
537 FEELING ABNORMAL 48 0.0002
538 BLOOD POTASSIUM DECREASED 6 0.0002
539 CELLULITIS 10 0.0002
540 LYMPHADENOPATHY 7 0.0002
541 HYPOTHERMIA 2 0.0002
542 DEVICE FAILURE 3 0.0002
543 INFUSION RELATED REACTION 13 0.0002
544 HIP ARTHROPLASTY 3 0.0002
545 EUPHORIC MOOD 2 0.0002
546 LOSS OF CONSCIOUSNESS 25 0.0002
547 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
548 EMOTIONAL DISORDER 6 0.0002
549 OSTEOPOROSIS 8 0.0002
550 HYPOTENSION 39 0.0002
551 TEMPERATURE INTOLERANCE 2 0.0002
552 ANKLE FRACTURE 3 0.0002
553 EJECTION FRACTION DECREASED 3 0.0002
554 VENTRICULAR EXTRASYSTOLES 2 0.0002
555 COUGH 54 0.0002
556 PHARMACEUTICAL PRODUCT COMPLAINT 5 0.0002
557 DIPLOPIA 5 0.0002
558 THERAPY PARTIAL RESPONDER 3 0.0002
559 BASAL CELL CARCINOMA 3 0.0002
560 SWOLLEN TONGUE 6 0.0002
561 PRODUCT SUBSTITUTION ISSUE 11 0.0002
562 KNEE ARTHROPLASTY 4 0.0002
563 BLOOD PRESSURE INCREASED 29 0.0002
564 HALLUCINATION, VISUAL 4 0.0002
565 JOINT DISLOCATION 2 0.0002
566 PNEUMOTHORAX 3 0.0002
567 HALLUCINATION, AUDITORY 3 0.0002
568 INFLUENZA 21 0.0002
569 EYE SWELLING 7 0.0002
570 IMPAIRED WORK ABILITY 4 0.0002
571 SENSORY DISTURBANCE 3 0.0002
572 WHEEZING 11 0.0002
573 MUSCLE TIGHTNESS 3 0.0002
574 THROAT TIGHTNESS 5 0.0002
575 MUSCULAR WEAKNESS 21 0.0002
576 COLITIS 7 0.0002
577 DEPRESSION 42 0.0002
578 RASH PRURITIC 10 0.0002
579 OEDEMA 10 0.0002
580 BIPOLAR DISORDER 2 0.0002
581 PRODUCT DISPENSING ERROR 4 0.0002
582 MANIA 3 0.0002
583 ABDOMINAL DISTENSION 19 0.0002
584 GASTROINTESTINAL PAIN 2 0.0002
585 INJECTION SITE NODULE 2 0.0002
586 BLOOD PRESSURE DECREASED 12 0.0002
587 FOOT DEFORMITY 2 0.0002
588 DRY EYE 9 0.0002
589 PROCEDURAL PAIN 5 0.0002
590 SYNCOPE 18 0.0002
591 ORAL PAIN 4 0.0002
592 THROAT IRRITATION 8 0.0002
593 OCULAR DISCOMFORT 2 0.0002
594 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
595 EYE INFECTION 2 0.0002
596 STATUS EPILEPTICUS 2 0.0002
597 PRODUCT DOSE OMISSION ISSUE 52 0.0002
598 IMPAIRED DRIVING ABILITY 2 0.0002
599 PAIN 108 0.0002
600 INTENTIONAL DOSE OMISSION 5 0.0002
601 SCAR 3 0.0002
602 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
603 HYPERSOMNIA 5 0.0002
604 NEPHROLITHIASIS 8 0.0002
605 LETHARGY 10 0.0002
606 MUSCLE TWITCHING 4 0.0002
607 MADAROSIS 2 0.0002
608 DYSKINESIA 7 0.0002
609 NAUSEA 136 0.0002
610 POST PROCEDURAL HAEMORRHAGE 2 0.0002
611 DYSPHONIA 10 0.0002
612 HEART RATE DECREASED 6 0.0002
613 PALPITATIONS 20 0.0002
614 SEPSIS 19 0.0002
615 BLOOD IRON DECREASED 2 0.0002
616 GALLBLADDER DISORDER 3 0.0002
617 RHABDOMYOLYSIS 7 0.0002
618 HYPERLIPIDAEMIA 2 0.0002
619 MUSCLE RIGIDITY 2 0.0002
620 DRUG EFFECT DECREASED 9 0.0002
621 WITHDRAWAL SYNDROME 7 0.0002
622 PAIN IN EXTREMITY 49 0.0002
623 IRRITABILITY 10 0.0002
624 THYROID CANCER 2 0.0002
625 OSTEOMYELITIS 3 0.0002
626 APHASIA 5 0.0002
627 LOCALISED INFECTION 4 0.0002
628 CRYING 6 0.0002
629 NOCTURIA 2 0.0002
630 BONE DISORDER 3 0.0002
631 PANIC ATTACK 6 0.0002
632 PRESYNCOPE 4 0.0002
633 END STAGE RENAL DISEASE 3 0.0002
634 PLEURAL EFFUSION 10 0.0002
635 NO THERAPEUTIC RESPONSE 2 0.0002
636 SUICIDAL IDEATION 15 0.0002
637 LIVER INJURY 4 0.0002
638 MUSCLE SPASTICITY 2 0.0002
639 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
640 SMALL INTESTINAL OBSTRUCTION 2 0.0002
641 CHILLS 19 0.0002
642 ABNORMAL WEIGHT GAIN 2 0.0002
643 VAGINAL HAEMORRHAGE 7 0.0002
644 ILEUS 2 0.0002
645 MENTAL DISORDER 7 0.0002
646 MIDDLE INSOMNIA 3 0.0002
647 HYPOAESTHESIA 24 0.0002
648 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
649 INTENTIONAL PRODUCT MISUSE 14 0.0002
650 SECRETION DISCHARGE 2 0.0002
651 HOT FLUSH 12 0.0002
652 BLOOD SODIUM DECREASED 3 0.0002
653 DERMATITIS ALLERGIC 2 0.0002
654 DIZZINESS 79 0.0002
655 ABDOMINAL PAIN LOWER 4 0.0002
656 BLOOD URINE PRESENT 3 0.0002
657 GASTRIC ULCER 3 0.0002
658 PULMONARY EMBOLISM 15 0.0002
659 HAEMATEMESIS 4 0.0002
660 FLUSHING 16 0.0002
661 BURNING SENSATION 11 0.0002
662 HYPOTHYROIDISM 5 0.0002
663 PULMONARY FIBROSIS 3 0.0002
664 LOWER LIMB FRACTURE 3 0.0002
665 GLAUCOMA 3 0.0002
666 GENITAL HAEMORRHAGE 2 0.0002
667 UNRESPONSIVE TO STIMULI 4 0.0002
668 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
669 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
670 NODULE 2 0.0002
671 FATIGUE 119 0.0002
672 MUSCULOSKELETAL PAIN 8 0.0002
673 GASTRITIS 4 0.0002
674 ORAL CANDIDIASIS 2 0.0002
675 HAEMATOCRIT DECREASED 3 0.0002
676 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
677 UPPER LIMB FRACTURE 3 0.0002
678 EXPIRED PRODUCT ADMINISTERED 5 0.0002
679 COGNITIVE DISORDER 7 0.0001
680 HAIR TEXTURE ABNORMAL 2 0.0001
681 JOINT RANGE OF MOTION DECREASED 2 0.0001
682 DIARRHOEA 96 0.0001
683 TYPE 2 DIABETES MELLITUS 5 0.0001
684 DISTURBANCE IN ATTENTION 8 0.0001
685 DYSGEUSIA 11 0.0001
686 TASTE DISORDER 3 0.0001
687 DEVICE BREAKAGE 6 0.0001
688 DISCOMFORT 9 0.0001
689 BODY TEMPERATURE INCREASED 3 0.0001
690 DRUG TOXICITY 2 0.0001
691 ABNORMAL LOSS OF WEIGHT 1 0.0001
692 MOOD ALTERED 4 0.0001
693 PRODUCTIVE COUGH 7 0.0001
694 NASOPHARYNGITIS 27 0.0001
695 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
696 INFECTION 21 0.0001
697 ANAPHYLACTIC REACTION 8 0.0001
698 DELIRIUM 5 0.0001
699 PULMONARY HYPERTENSION 3 0.0001
700 POLLAKIURIA 6 0.0001
701 WEIGHT DECREASED 40 0.0001
702 PERIPHERAL SWELLING 22 0.0001
703 MOUTH ULCERATION 3 0.0001
704 DEVICE OCCLUSION 2 0.0001
705 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
706 HYPOXIA 5 0.0001
707 ABDOMINAL PAIN 33 0.0001
708 TARDIVE DYSKINESIA 4 0.0001
709 FLATULENCE 8 0.0001
710 SUBDURAL HAEMATOMA 2 0.0001
711 CEREBRAL HAEMORRHAGE 5 0.0001
712 OEDEMA PERIPHERAL 17 0.0001
713 RHINORRHOEA 9 0.0001
714 MALAISE 61 0.0001
715 DRUG INTERACTION 22 0.0001
716 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
717 DEVICE LEAKAGE 6 0.0001
718 SWELLING FACE 9 0.0001
719 ANOSMIA 2 0.0001
720 ASCITES 4 0.0001
721 PNEUMONIA 44 0.0001
722 INFLAMMATION 7 0.0001
723 DYSPNOEA 76 0.0001
724 COLON CANCER 2 0.0001
725 RASH PAPULAR 3 0.0001
726 RESPIRATORY DISORDER 4 0.0001
727 INFLUENZA LIKE ILLNESS 11 0.0001
728 PANCREATITIS ACUTE 3 0.0001
729 CHROMATURIA 3 0.0001
730 INTESTINAL OBSTRUCTION 5 0.0001
731 TREMOR 22 0.0001
732 LACRIMATION INCREASED 4 0.0001
733 HYPERTENSION 28 0.0001
734 DRUG ABUSE 11 0.0001
735 BLOOD COUNT ABNORMAL 2 0.0001
736 VOMITING 62 0.0001
737 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
738 DRUG DISPENSING ERROR 2 0.0001
739 EPILEPSY 4 0.0001
740 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
741 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
742 PHARYNGEAL OEDEMA 2 0.0001
743 HYPOKALAEMIA 6 0.0001
744 WEIGHT INCREASED 29 0.0001
745 HYPERSENSITIVITY 24 0.0001
746 SOMNOLENCE 26 0.0001
747 RENAL DISORDER 6 0.0001
748 RENAL FAILURE 17 0.0001
749 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 23 0.0001
750 DEHYDRATION 17 0.0001
751 CYANOSIS 2 0.0001
752 ARTHROPATHY 7 0.0001
753 CYSTITIS 4 0.0001
754 PREMATURE DELIVERY 2 0.0001
755 GAIT DISTURBANCE 24 0.0001
756 ASTHENIA 47 0.0001
757 BLOOD PRESSURE FLUCTUATION 3 0.0001
758 CONDITION AGGRAVATED 38 0.0001
759 MOVEMENT DISORDER 4 0.0001
760 DRUG INTOLERANCE 12 0.0001
761 CONFUSIONAL STATE 20 0.0001
762 BLOOD POTASSIUM INCREASED 2 0.0001
763 AGITATION 9 0.0001
764 METASTASES TO BONE 2 0.0001
765 IMPAIRED HEALING 4 0.0001
766 HERPES ZOSTER 7 0.0001
767 OSTEONECROSIS 4 0.0001
768 MULTIPLE FRACTURES 2 0.0001
769 PHOTOSENSITIVITY REACTION 2 0.0001
770 EXTRAPYRAMIDAL DISORDER 3 0.0001
771 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
772 DECREASED APPETITE 28 0.0001
773 INJECTION SITE PRURITUS 8 0.0001
774 PERICARDITIS 2 0.0001
775 HEMIPARESIS 2 0.0001
776 CATARACT 7 0.0001
777 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
778 GASTRIC DISORDER 4 0.0001
779 THROMBOCYTOPENIA 13 0.0001
780 PARANOIA 2 0.0001
781 HAEMATOMA 3 0.0001
782 EXPOSURE VIA SKIN CONTACT 3 0.0001
783 ORTHOSTATIC HYPOTENSION 2 0.0001
784 DEAFNESS 3 0.0001
785 DEVICE USE ISSUE 2 0.0001
786 MUSCULOSKELETAL STIFFNESS 10 0.0001
787 DEPRESSED MOOD 6 0.0001
788 ABDOMINAL DISCOMFORT 19 0.0001
789 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
790 EXPOSURE DURING PREGNANCY 7 0.0001
791 CEREBROVASCULAR ACCIDENT 19 0.0001
792 ISCHAEMIC STROKE 2 0.0001
793 COMPLICATION OF DEVICE REMOVAL 2 0.0001
794 PRODUCT QUALITY ISSUE 15 0.0001
795 RESPIRATORY FAILURE 8 0.0001
796 SKIN LESION 3 0.0001
797 RESTLESSNESS 4 0.0001
798 MUSCLE SPASMS 20 0.0001
799 RESPIRATORY DISTRESS 3 0.0001
800 ABNORMAL DREAMS 3 0.0001
801 BLOOD GLUCOSE ABNORMAL 2 0.0001
802 OROPHARYNGEAL PAIN 10 0.0001
803 MENTAL STATUS CHANGES 3 0.0001
804 FEELING COLD 3 0.0001
805 URTICARIA 18 0.0001
806 HEPATIC STEATOSIS 2 0.0001
807 THINKING ABNORMAL 2 0.0001
808 WOUND 3 0.0001
809 RENAL IMPAIRMENT 9 0.0001
810 CARDIAC DISORDER 10 0.0001
811 HEPATIC CIRRHOSIS 2 0.0001
812 PRODUCT USE ISSUE 20 0.0001
813 EYE PAIN 6 0.0001
814 HYPOCALCAEMIA 2 0.0001
815 CONSTIPATION 23 0.0001
816 DYSPHAGIA 10 0.0001
817 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
818 PROTEINURIA 2 0.0001
819 MUSCULOSKELETAL DISORDER 2 0.0001
820 FEELING JITTERY 2 0.0001
821 VISUAL IMPAIRMENT 13 0.0001
822 RASH ERYTHEMATOUS 5 0.0001
823 MULTIPLE SCLEROSIS 5 0.0001
824 CHOLESTASIS 2 0.0001
825 HOSPITALISATION 16 0.0001
826 DYSSTASIA 3 0.0001
827 ORAL HERPES 2 0.0001
828 PRURITUS 39 0.0001
829 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
830 PRESCRIBED UNDERDOSE 2 0.0001
831 SPINAL FRACTURE 2 0.0001
832 ANAEMIA 19 0.0001
833 SLEEP DISORDER 7 0.0001
834 RASH 43 0.0001
835 BLINDNESS 4 0.0001
836 INJECTION SITE RASH 3 0.0001
837 DRUG ADMINISTRATION ERROR 3 0.0001
838 HAEMOGLOBIN DECREASED 10 0.0001
839 PRODUCT PREPARATION ERROR 2 0.0001
840 LIMB DISCOMFORT 3 0.0001
841 FEMUR FRACTURE 3 0.0001
842 PRODUCT USE IN UNAPPROVED INDICATION 24 0.0001
843 ALOPECIA 19 0.0001
844 NERVOUS SYSTEM DISORDER 3 0.0001
845 MOOD SWINGS 3 0.0001
846 EATING DISORDER 2 0.0001
847 EPISTAXIS 7 0.0001
848 IRRITABLE BOWEL SYNDROME 2 0.0001
849 LIVER FUNCTION TEST INCREASED 2 0.0001
850 HALLUCINATION 7 0.0001
851 PRURITUS GENERALISED 2 0.0001
852 FAECES DISCOLOURED 2 0.0001
853 AMNESIA 6 0.0001
854 PRODUCT DOSE OMISSION 6 0.0001
855 BLOOD CREATININE INCREASED 6 0.0001
856 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
857 DEPENDENCE 5 0.0001
858 MELAENA 2 0.0001
859 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
860 LIVER DISORDER 4 0.0001
861 LIP SWELLING 3 0.0001
862 MEDICATION ERROR 5 0.0001
863 URINARY RETENTION 3 0.0001
864 COLITIS ULCERATIVE 4 0.0001
865 GLOSSODYNIA 2 0.0001
866 ARTHRALGIA 37 0.0001
867 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001
868 INJECTION SITE BRUISING 7 0.0001
869 VISION BLURRED 12 0.0001
870 DRUG INEFFECTIVE 115 0.0001
871 NIGHTMARE 3 0.0001
872 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
873 BLOOD CHOLESTEROL INCREASED 4 0.0001
874 PLATELET COUNT DECREASED 9 0.0001
875 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
876 PSORIASIS 11 0.0001
877 PRODUCT PRESCRIBING ERROR 2 0.0001
878 PRODUCT ADHESION ISSUE 3 0.0001
879 ACCIDENT 1 0.0001
880 BLOOD GLUCOSE DECREASED 4 0.0001
881 DRUG EFFECT INCOMPLETE 3 0.0001
882 HYPOGLYCAEMIA 4 0.0001
883 STOMATITIS 5 0.0001
884 HYPERGLYCAEMIA 3 0.0001
885 ACCIDENTAL OVERDOSE 3 0.0001
886 FEELING HOT 5 0.0001
887 INJECTION SITE MASS 3 0.0001
888 ABASIA 2 0.0001
889 DRUG DEPENDENCE 13 0.0001
890 MYOCARDIAL INFARCTION 14 0.0001
891 LEUKOPENIA 4 0.0001
892 HYPOPHAGIA 2 0.0001
893 DEVICE ISSUE 7 0.0001
894 PYREXIA 27 0.0001
895 RASH GENERALISED 2 0.0001
896 MYALGIA 13 0.0001
897 ECZEMA 4 0.0001
898 ABNORMAL BEHAVIOUR 3 0.0001
899 MENSTRUATION IRREGULAR 2 0.0001
900 EXTRA DOSE ADMINISTERED 3 0.0001
901 FREQUENT BOWEL MOVEMENTS 2 0.0001
902 PSORIATIC ARTHROPATHY 3 0.0001
903 HAEMATOCHEZIA 4 0.0001
904 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
905 HAEMOPTYSIS 2 0.0001
906 DEMENTIA 2 0.0001
907 SKIN EXFOLIATION 6 0.0001
908 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
909 RHEUMATOID ARTHRITIS 8 0.0001
910 MOBILITY DECREASED 5 0.0001
911 UNDERDOSE 5 0.0001
912 ACUTE MYOCARDIAL INFARCTION 2 0.0001
913 LABORATORY TEST ABNORMAL 2 0.0001
914 RENAL INJURY 2 0.0001
915 PULMONARY OEDEMA 3 0.0001
916 ADVERSE DRUG REACTION 6 0.0001
917 THERAPEUTIC RESPONSE DECREASED 4 0.0001
918 SKIN DISCOLOURATION 3 0.0001
919 INJECTION SITE SWELLING 5 0.0001
920 ACUTE MYELOID LEUKAEMIA 1 0.0001
921 DRUG-INDUCED LIVER INJURY 2 0.0001
922 CARDIAC FAILURE CONGESTIVE 5 0.0001
923 HIP FRACTURE 2 0.0001
924 INTERSTITIAL LUNG DISEASE 3 0.0001
925 ATRIAL FIBRILLATION 6 0.0001
926 EYE DISORDER 2 0.0001
927 OFF LABEL USE 53 0.0001
928 DEVICE DIFFICULT TO USE 4 0.0001
929 VISUAL ACUITY REDUCED 2 0.0001
930 SKIN DISORDER 2 0.0001
931 NEOPLASM MALIGNANT 4 0.0001
932 ANGER 2 0.0001
933 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
934 THERAPY CESSATION 3 0.0001
935 ERYTHEMA 12 0.0001
936 INJECTION SITE REACTION 4 0.0001
937 JOINT SWELLING 7 0.0001
938 DEVICE USE ERROR 2 0.0001
939 NEOPLASM PROGRESSION 2 0.0001
940 DRUG WITHDRAWAL SYNDROME 5 0.0001
941 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
942 THERAPY INTERRUPTED 4 0.0001
943 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
944 DRUG DOSE OMISSION 9 0.0001
945 DYSURIA 2 0.0001
946 HEPATIC FUNCTION ABNORMAL 2 0.0001
947 OXYGEN SATURATION DECREASED 3 0.0001
948 HYPONATRAEMIA 3 0.0001
949 CONVULSION 3 0.0001
950 ACUTE RESPIRATORY FAILURE 1 0.0001
951 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
952 BONE PAIN 3 0.0001
953 DISORIENTATION 2 0.0001
954 INJECTION SITE HAEMORRHAGE 4 0.0001
955 CARDIAC FAILURE 4 0.0000
956 ILL-DEFINED DISORDER 3 0.0000
957 NEUTROPHIL COUNT DECREASED 2 0.0000
958 INJECTION SITE ERYTHEMA 6 0.0000
959 INCORRECT DOSE ADMINISTERED 11 0.0000
960 BLOOD GLUCOSE INCREASED 9 0.0000
961 INTENTIONAL OVERDOSE 3 0.0000
962 RECTAL HAEMORRHAGE 2 0.0000
963 HYPOACUSIS 2 0.0000
964 FEBRILE NEUTROPENIA 3 0.0000
965 DRY SKIN 6 0.0000
966 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
967 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
968 BREAST CANCER 4 0.0000
969 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
970 INJECTION SITE PAIN 13 0.0000
971 LUNG DISORDER 2 0.0000
972 AGGRESSION 2 0.0000
973 ACNE 3 0.0000
974 DIABETES MELLITUS 3 0.0000
975 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
976 DEATH 33 0.0000
977 DERMATITIS ATOPIC 2 0.0000
978 TREATMENT NONCOMPLIANCE 2 0.0000
979 BLISTER 2 0.0000
980 EYE IRRITATION 2 0.0000
981 NO ADVERSE EVENT 6 0.0000
982 HEPATIC ENZYME INCREASED 2 0.0000
983 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
984 HAEMORRHAGE 3 0.0000
985 DEVICE MALFUNCTION 2 0.0000
986 ABORTION SPONTANEOUS 1 0.0000
987 PRODUCT STORAGE ERROR 2 0.0000
988 NEUTROPENIA 3 0.0000
989 ADVERSE EVENT 2 0.0000
990 DISEASE PROGRESSION 2 0.0000